Clinical Trial Update: Evaluating Lung Doppler Signals in Patients With Systemic Sclerosis (SSc) [NA]

View source ↗

Summary

The clinical trial evaluating lung Doppler signals in patients with systemic sclerosis and pulmonary hypertension has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension
• Systemic Sclerosis

Snippet

Sponsor: Echosense Ltd. | Conditions: Systemic Sclerosis, Pulmonary Hypertension | NA | Status: TERMINATED